Parkinsons Disease at IgMin Research | Medicine Group
We advocate for multi-field collaboration to ensure a quicker pace of discovery and development.
About
Parkinson's Disease is a progressive neurological disorder that profoundly impacts motor and non-motor functions. This complex condition arises due to the degeneration of dopamine-producing neurons in the brain, leading to symptoms such as tremors, rigidity, bradykinesia, and postural instability. Research into Parkinson's Disease spans diverse fields, including neurobiology, genetics, and pharmacology, aiming to uncover its underlying mechanisms and develop innovative treatments.
Advances in the understanding and management of Parkinson's Disease are driving the development of therapies that improve quality of life and slow disease progression. From exploring the role of neuroinflammation to leveraging precision medicine, this field is at the forefront of neuroscience research. Parkinson's Disease studies hold immense promise for uncovering insights into neurodegenerative processes, fostering breakthroughs that could benefit millions worldwide.
Why publish with us?
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
Which articles are now trending?
Research Articles
- Comparing Forecasting Models for Predicting Infant Mortality: VECM vs. VAR and BVAR Specifications
- A Comprehensive Methodology for Assessing the Business Reputation of Industrial and Production Personnel
- Lunar-Derived Propellants for Fueling Mars-Bound Spacecraft in Cis-Lunar Space
- Evaluating Digital Imaging Technologies for Anogenital Injury Documentation in Sexual Assault Cases
- Examining the Causal Connection between Lipid-lowering Medications and Malignant Meningiomas through Drug-target Mendelian Randomization Analysis
- A New Modification of Classification of Traumatic Patients with Pelvic Fracture
